NCT06001385 2026-02-05OPTIMIZECenter for International Blood and Marrow Transplant ResearchPhase 2 Active not recruiting313 enrolled
NCT03613532 2025-12-24Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPNDana-Farber Cancer InstitutePhase 1 Active not recruiting102 enrolled
NCT00544115 2025-06-10Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersCity of Hope Medical CenterPhase 2 Active not recruiting260 enrolled 13 charts